Transcriptional targets for pituitary tumor-transforming gene-1

Journal of Molecular Endocrinology

Volumn 43, Issue 5, 2009, Pages 179-185

  Tong, Yunguang ^a   Eigler, Tamar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D3; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; MYC PROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN P21; PROTEIN P53; SECURIN; TRANSCRIPTION FACTOR; UPSTREAM STIMULATORY FACTOR 1;

ANGIOGENESIS; CARCINOGENESIS; CELL CYCLE; CELL STRAIN 3T3; CELL TRANSFORMATION; CHROMATIN IMMUNOPRECIPITATION; DNA BINDING; GENE FUNCTION; GENE TARGETING; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HYPOPHYSIS TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; TUMOR CELL;

ANIMALS; CYCLIN D3; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70449671109     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-08-0176     Document Type: Review

References (53)

1. Bernal JA, Luna R, Espina A, Luzaro I, Ramos-Morales F, Romero F, Arias C, Silva A, Tortolero M & Pintor-Toro JA 2002 Human securin interacts with p53-mediated transcriptional activity and apoptosis. Nature Genetics 32 306-311.
2. Boelaert K, McCabe CJ, Tannahill LA, Gittoes NJ, Holder RL, Watkinson JC, Bradwell AR, Sheppard MC & Franklyn JA 2003 Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism 88 2341-2347. (Pubitemid 36549916)
3. Boelaert K, Yu R, Tannahill LA, Stratford AL, Khanim FL, Eggo MC, Moore JS, Young LS, Gittoes NJL, Franklyn JA et al. 2004 PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro. Journal of Molecular Endocrinology 33 663-677. (Pubitemid 40057561)
4. Boelaert K, Smith VE, Stratford AL, Kogai T, Tannahill LA, Watkinson JC, Eggo MC, Franklyn JA & McCabe CJ 2007 PTTG and PBF repress the human sodium iodide symporter. Oncogene 26 4344-4356. (Pubitemid 47014460)
5. Chamaon K, Kirches E, Kanakis D, Braeuninger S, Dietzmann K & Mawrin C 2005 Regulation of the pituitary tumor transforming gene by insulin-like-growth factor-I and insulin differs between malignant and non-neoplastic astrocytes. Biochemical and Biophysical Research Communications 331 86-92. (Pubitemid 40545146)
6. +/- pituitary tumorigenesis. Molecular Endocrinology 19 2371-2379.
7. Chesnokova V, Zonis S, Rubinek T, Yu R, Ben-Shlomo A, Kovacs K, Wawrowsky K & Melmed S 2007 Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Research 67 10564-10572. (Pubitemid 350070833)
8. Chesnokova V, Zonis S, Kovacs K, Ben-Shlomo A, Wawrowsky K, Bannykh S & Melmed S 2008 p21(Cip1) restrains pituitary tumor growth. PNAS 105 17498-17503.
9. Chien W & Pei L 2000 A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. Journal of Biological Chemistry 275 19422-19427. (Pubitemid 30422919)
10. Cho-Rok J, Yoo J, Jang YJ, Kim S, Chu IS, Yeom YI, Choi JY & Im DS 2006 Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo. Hepatology 43 1042-1052. (Pubitemid 43724628)
11. Dominguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M & Pintor-Toro JA 1998 hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene 17 2187-2193.
12. Hamid T & Kakar SS 2004 PTTG/securin activates expression of p53 and modulates its function. Molecular Cancer 3 18. (Pubitemid 40230554)
13. Heaney AP, Horwitz GA, Wang Z, Singson R & Melmed S 1999 Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nature Medicine 5 1317-1321. (Pubitemid 29535612)
14. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M & Melmed S 2000 Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355 716-719. (Pubitemid 30107628)
15. Heaney AP, Nelson V, Fernando M & Horwitz G 2001 Transforming events in thyroid tumorigenesis and their association with follicular lesions. Journal of Clinical Endocrinology and Metabolism 86 5025-5032. (Pubitemid 33020559)
16. Hlubek F, Pfeiffer S, Budczies J, Spaderna S, Jung A, Kirchner T & Brabletz T 2006 Securin (hPTTG1) expression is regulated by beta-catenin/TCF in human colorectal carcinoma. British Journal of Cancer 94 1672-1677. (Pubitemid 43924931)
17. Honda S, Hayashi M, Kobayashi Y, Ishikawa Y, Nakagawa K & Tsuchiya E 2003 A role for the pituitary tumor-transforming gene in the genesis and progression of non-small cell lung carcinomas. Anticancer Research 23 3775-3782. (Pubitemid 37474324)
18. Horwitz GA, Miklovsky I, Heaney AP, Ren SG & Melmed S 2003 Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression. Molecular Endocrinology 17 600-609. (Pubitemid 36403573)
19. Hunter JA, Skelly RH, Aylwin SJ, Geddes JF, Evanson J, Besser GM, Monson JP & Burrin JM 2003 The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. European Journal of Endocrinology 148 203-211. (Pubitemid 36305686)
20. Ishikawa H, Heaney AP, Yu R, Horwitz GA & Melmed S 2001 Human pituitary tumor-transforming gene induces angiogenesis. Journal of Clinical Endocrinology and Metabolism 86 867-874. (Pubitemid 32207508)
21. Kakar SS 1999 Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG). Gene 240 317-324.
22. Kakar SS & Jennes L 1999 Molecular cloning and characterization of the tumor transforming gene (TUTR1): a novel gene in human tumorigenesis. Cytogenetics and Cell Genetics 84 211-216. (Pubitemid 29294968)
23. Kakar SS & Malik MT 2006 Suppression of lung cancer with siRNA targeting PTTG. International Journal of Oncology 29 387-395.
24. Kim DS, Franklyn JA, Smith VE, Stratford AL, Pemberton HN, Warfield A, Watkinson JC, Ishmail T, Wakelam MJO & McCabe CJ 2007a Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis 28 749-759. (Pubitemid 46523373)
25. Kim CS, Ying H, Willingham MC & Cheng SY 2007b The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer. Carcinogenesis 28 932-939. (Pubitemid 47072175)
26. Lee IA, Seong C & Choe IS 1999 Cloning and expression of human cDNA encoding human homologue of pituitary tumor transforming gene. Biochemistry and Molecular Biology International 47 891-897. (Pubitemid 29240508)
27. Liabakk NB, Talbot I, Smith RA, Wilkinson K & Balkwill F 1996 Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Research 56 190-196. (Pubitemid 26010399)
28. Malik MT & Kakar SS 2006 Regulation of angiogenesis and invasion by human pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2). Molecular Cancer 5 61.
29. McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA & Gittoes NJL 2002 Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. Journal of Clinical Endocrinology and Metabolism 87 4238-4244.
30. McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC, Franklyn JA et al. 2003 Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clinical Endocrinology 58 141-150. (Pubitemid 36194267)
31. Pei L 2000 Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function. Journal of Biological Chemistry 275 31191-31198. (Pubitemid 30757781)
32. Pei L 2001 Identification of c-myc as a down-stream target for pituitary tumor-transforming gene. Journal of Biological Chemistry 276 8484-8491. (Pubitemid 37385662)
33. Pei L & Melmed S 1997 Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Molecular Endocrinology 11 433-441. (Pubitemid 27147011)
34. Ptashne M 1988 How eukaryotic transcriptional activators work. Nature 335 683-689. (Pubitemid 18242890)
35. Puri R, Tousson A, Chen L & Kakar SS 2001 Molecular cloning of pituitary tumor transforming gene 1 from ovarian tumors and its expression in tumors. Cancer Letters 163 131-139. (Pubitemid 32121839)
36. Ramaswamy S, Ross KN, Lander ES & Golub TR 2003 A molecular signature of metastasis in primary solid tumors. Nature Genetics 33 49-54. (Pubitemid 36068681)
37. Rehfeld N, Geddert H, Atamna A, Rohrbeck A, Garcia G, Kliszewski S, Neukirchen J, Bruns I, Steidl U, Fenk R et al. 2006 The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer. Journal of Carcinogenesis 5 4. (Pubitemid 43193507)
38. Romero F, Multon MC, Ramos-Morales F, Dominguez A, Bernal JA, Pintor-Toro JA & Tortolero M 2001 Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. Nucleic Acids Research 29 1300-1307. (Pubitemid 32229457)
39. Saez C, Japon MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M & Pintor-Toro JA 1999 hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 18 5473-5476. (Pubitemid 29469235)
40. Sanchez-Puig N, Veprintsev DB & Fersht AR 2005 Human full-length securin is a natively unfolded protein. Protein Science 14 1410-1418. (Pubitemid 41014813)
41. Shibata Y, Haruki N, Kuwabara Y, Nishiwaki T, Kato J, Shinoda N, Sato A, Kimura M, Koyama H, Toyama T et al. 2002 Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Japanese Journal of Clinical Oncology 32 233-237. (Pubitemid 43102805)
42. Solbach C, Roller M, Fellbaum C, Nicoletti M & Kaufmann M 2004 PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence. Breast 13 80-81. (Pubitemid 38228595)
43. Tong Y, Tan Y, Zhou C & Melmed S 2007 Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition. Oncogene 26 5596-5605. (Pubitemid 47267833)
44. Tong Y, Ben-Shlomo A, Zhou C, Wawrowsky K & Melmed S 2008 Pituitary tumor transforming gene 1 regulates Aurora kinase A activity. Oncogene 27 6385-6395.
45. Tsai SJ, Lin SJ, Cheng YM, Chen HM & Wing LY 2005 Expression and functional analysis of pituitary tumor transforming growth factor-1 in uterine leiomyomas. Journal of Clinical Endocrinology and Metabolism 90 3715-3723.
46. Waizenegger I, Gimenez-Abian JF, Wernic D & Peters JM 2002 Regulation of human separase by securin binding and autocleavage. Current Biology 12 1368-1378. (Pubitemid 34915538)
47. Wang Z, Yu R & Melmed S 2001 Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Molecular Endocrinology 15 1870-1879. (Pubitemid 33022528)
48. Wang Z, Moro E, Kovacs K, Yu R & Melmed S 2003 Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes. PNAS 100 3428-3432. (Pubitemid 36356600)
49. Yu R, Heaney AP, Lu W, Chen J & Melmed S 2000 Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis. Journal of Biological Chemistry 275 36502-36505. (Pubitemid 32002045)
50. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD & Melmed S 1999a Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 84 761-767. (Pubitemid 29075718)
51. Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD & Melmed S 1999b Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Molecular Endocrinology 13 156-166. (Pubitemid 29022288)
52. Zou H, McGarry TJ, Bernal T & Kirschner MW 1999 Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285 418-422. (Pubitemid 29343966)
53. Zur A & Brandeis M 2001 Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis. EMBO Journal 20 792-801. (Pubitemid 32167643)